Oncolytics Biotech Cash Flow Statement (2009-2025) | ONCY

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-5.08M-5.89M-3.87M35.59M-5.35M4.00M-3.38M30.29M-4.76M15.12M7.40M2.90M-5.12M-5.31M-7.00M39.66M-4.66M-4.45M-10.46M
Depreciation and Depletion (Quarter)
0.07M0.07M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.07M0.05M50.580.22M0.05M0.05M50.14
Share-based Compensation (Quarter)
0.52M0.84M0.80M-2.14M0.50M0.38M0.38M0.55M0.23M0.18M-0.30M0.43M0.37M0.33M0.86M0.84M0.38M2.99M
Deferred Taxes (Quarter)
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)
0.13M-0.07M-0.04M-0.04M0.01M-0.03M0.01M0.02M-0.02M0.08M-0.38M-3.56M-0.64M-0.17M-0.17M0.07M-0.17M0.14M0.76M
Non-cash Items (Quarter)
Change in Working Capital (Quarter)
-0.47M-1.14M0.97M1.34M-0.52M-1.26M0.62M1.36M-1.15M-1.40M2.74M1.12M-0.02M0.16M3.16M-0.69M-0.60M-0.16M1.88M
Change in Account Payables (Quarter)
2.28M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-0.09M-0.08M-0.06M-0.06M-0.07M-0.07M-0.07M-0.08M-0.07M-0.07M-0.08M-0.08M-0.08M-0.05M-0.06M-0.07M-0.07M-0.07M-0.07M
Cash from Operations (Quarter)
-4.40M-5.53M-2.97M-5.03M-4.94M-5.43M-3.26M-4.38M-5.79M-6.30M-4.50M-4.50M-5.54M-4.99M-3.54M-5.62M-4.53M-3.95M-4.83M-20.09M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.02M0.06M0.01M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.01M0.01M0.02M0.02M0.03M0.02M0.02M0.02M0.02M
Investing Activities
Capital Expenditures (Quarter)
-0.01M-0.16M0.39M-0.03M-0.01M-0.01M736.70-0.00M-0.00M-0.03M-0.11M-0.02M-0.00M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
4.94M5.05M5.05M
Cash from Investing Activities (Quarter)
-0.01M-0.16M-0.06M-0.03M-0.01M-0.01M-14.99M4.93M5.05M5.05M-0.00M-0.03M-0.11M-0.02M-0.00M-0.01M
Financing Activities
Other financing activities (Quarter)
0.15M0.01M0.00M0.03M0.01M0.05M0.28M
Change in Capital Stock
Shares Issued (Quarter)
Net Equity Issued and Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)
19.88M6.49M-0.06M-0.04M3.96M0.12M0.89M4.32M3.90M2.75M15.88M1.28M1.11M1.44M-0.13M2.39M4.10M3.88M3.01M14.10M
Exchange Rate Effect (Quarter)
-0.36M-0.60M1.04M-0.29M-0.40M0.77M1.35M-0.21M0.07M-0.27M0.33M-0.50M0.53M0.18M-0.16M0.61M-0.02M-0.42M0.24M0.12M
Change in Cash (Quarter)
15.48M0.96M-3.19M-5.13M-1.01M-5.31M-2.37M-15.04M3.04M1.50M16.43M-3.22M-4.47M-3.65M-3.69M-3.23M-0.42M-0.07M-1.83M-5.89M
Beginning Cash Balance (Quarter)
24.67M40.97M40.36M337.9632.58M30.97M8.63M25.91M11.11M
Free Cash Flow (Quarter)
-4.40M-5.52M-2.80M-5.42M-4.91M-5.42M-3.25M-4.38M-5.79M-6.30M-4.50M-4.50M-5.51M-4.87M-3.52M-5.61M-4.53M-3.95M-4.83M-20.09M
Net Cash Flow (Quarter)
15.48M0.96M-3.19M-5.13M-1.01M-5.31M-2.37M-15.04M3.04M1.50M16.43M-3.22M-4.47M-3.65M-3.69M-3.23M-0.42M-0.07M-1.83M-6.00M